Brands
Cannara Biotech’s brands, including Tribal, deliver premium cannabis products with distinct identities in Canada.
cannara.caCrawled Nov 21, 2026
Cannara Biotech’s brands, including Tribal, deliver premium cannabis products with distinct identities in Canada.
British Columbia Digital Asset Library BC Product Guide
Cannara Biotech announced the launch of three new brands—Tribal, Nugz, and Orchid CBD—in February 2021.
The page highlights women’s leadership in shaping Canada’s regulated cannabis industry, featuring profiles of Maria and Sabrina at Cannara Biotech.
ANALYST COVERAGE Research Capital Greg McLeish, CFA Contact Analyst Coverage as of July 7, 2025 Latest Report January 27, 2026 ATRIUM RESEARCH Nicholas Cortellucci, CFA | Contact Luca Perna | Contact Analyst Coverage as of March 03, 2026 Latest Report July 15, 2026 TD COWEN Derek J. Lessard | Contact Ryan Neal | Contact Analyst Coverage […]
Cannara Biotech raised $2.16 million through a non-brokered private placement of common shares in July 2019.
Cannara Biotech secured a $6 million first mortgage against its Farnham Facility in October 2019.
Press Releases 2026 Edit Date Title Download Link 02/26/2026 Cannara Announces Graduation to the Toronto Stock Exchange View 02/11/2026 Cannara to Host Investor Webcast on February 19th, 2026 View 02/04/2026 Cannara Announces Strategic C$6.3 Million Non-Brokered Private Placement Priced at C$2.10 per Common Share View 01/28/2026 Cannara Announces Conditional Approval to List on the Toronto […]
Cannara Biotech offers career opportunities in the cannabis industry, emphasizing leadership and innovation.
Cannara Biotech mobilizes resources to produce premium cannabis products for adult consumers in a highly regulated market.
Board of Directors Zohar Krivorot | Chairman Zohar is an entrepreneur who has launched several successful businesses. He has founded, advised and invested in numerous companies including 911ENABLE which he led from start-up to its acquisition by West Telecom in 2014. Zohar has been recognized as a top leader and innovator by a number of […]
Management Team Zohar Krivorot | Chief Executive Officer Zohar is an entrepreneur who has launched several successful businesses. He has founded, advised and invested in numerous companies including 911ENABLE which he led from start-up to its acquisition by West Telecom in 2014. Zohar has been recognized as a top leader and innovator by a number […]
Cannara Biotech operates two facilities spanning over 1.6 million square feet, producing up to 100,000 kg of cannabis annually.
Cannara Biotech delivers premium cannabis products at accessible prices, guided by quality and affordability principles.
Cannara Biotech emphasizes quality in product design and customer support, addressing issues for recent purchasers.
Cannara Biotech is a vertically integrated producer of premium cannabis and cannabis-derivative products for Quebec and Canadian markets.
Cannara Biotech products are available at licensed cannabis retailers across Canada, with a store locator tool for finding nearby locations.
Cannara Biotech focuses on cultivating premium cannabis flower to create consistent products, shaping Canada’s cannabis industry.
Cannara Biotech will disclose its **fiscal Q4 and full-year 2026 financial results** on **November 30, 2026**. The company’s **Chief Operating Officer and Interim Chief Financial Officer, Nicholas Sosiak**, will lead an earnings webcast scheduled for **July 15, 2026, at 11:00 AM ET**. The announcement marks a key update for investors ahead of the formal earnings release.
Cannara Biotech has extended its international supply partnership with Curaleaf, a leading cannabis company. The agreement strengthens their global distribution network, though specific terms or product details are not disclosed. Nicholas Sosiak, Cannara’s COO and interim CFO, will discuss financial updates in an upcoming earnings webcast.
Cannara Biotech secures an **$80 million syndicated credit facility** from BMO and TD Bank to bolster its financial stability. The funding supports continued growth and operational expansion. Nicholas Sosiak, COO and Interim CFO, will lead an earnings webcast on **July 15, 2026**, to discuss financial updates.
Cannara Biotech has appointed Nicholas Fozard as its new Chief Financial Officer. The company previously named Nicholas Sosiak as interim CFO while he served as Chief Operating Officer. Cannara Biotech will host an earnings webcast on July 15, 2026, at 11:00 AM ET.
Cannara Biotech reports record third-quarter revenues and sustained profitability while expanding its national distribution network. The company accelerates capacity expansion to meet growing demand. Nicholas Sosiak, COO and interim CFO, will host an earnings webcast on July 15, 2026.